LBP-EC01 0.1 x IV dose for escherichia coli infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Jul 2022: Trial started, NCT05488340
  2. 4 Aug 2022: Trial registered, NCT05488340

The trials

NCT05488340: A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

State
Under way
Phase
Phase 2
People
318 planned
Started
13 Jul 2022
Primary completion
Jun 2027
Arms
Part 1- Arm 4 (previously 1)
Results
None posted
  1. 13 Jul 2022: Trial started
  2. 4 Aug 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.